Business
Novocure Announces Recipients of 2nd Annual AACR-Novocure Grants for Tumor Treating Fields Research Program
ST. HELIER, Jersey--(BUSINESS WIRE)-- Novocure (NASDAQ:NVCR) announced today the recipients of the AACR-Novocure Grants for Tumor Treating Fields Research
About this update from Novocure Limited
[{"type":"text","content":" ST. HELIER, Jersey--(BUSINESS WIRE)--\nNovocure (NASDAQ:NVCR) announced today the recipients of the AACR-Novocure Grants for Tumor Treating Fields Research program. The program represents a joint effort between Novocure and the American Association for Cancer Research (AACR) to promote and support innovative research on Tumor Treating Fields. The AACR is the first and largest cancer research organization dedicated to accelerating the conquest of cancer.\n\n\nSuch collaborations help to deepen the understanding of the mechanism of action and to accelerate the development of new treatment strategies. Extensive preclinical and clinical evidence provides the foundation upon which Novocure executes its strategy to advance Tumor Treating Fields through additional clinical research studies across multiple solid tumor types.\n\n\n“Congratulations to the recipients of the AACR-Novocure Grants for Tumor Treating Fields Research,” said Asaf Danziger, Novocure’s Chief Executive Officer. “We value our ongoing partnership with the AACR as we continue to deepen our understanding of the mechanism of action of Tumor Treating Fields. We look forward to learning the outcomes of the impressive research planned by our grant recipients.”\n\n\n“The AACR is thrilled to welcome its newest class of grant recipients, including the recipients of the AACR-Novocure Grants for Tumor Treating Fields,” said Mitch Stoller, the AACR’s Chief Philanthropic Officer. “Our continued partnership with Novocure has played a pivotal role in providing crucially needed resources to scientists on the leading edge of discovery. The innovative research supported by these grants will contribute to our understanding of Tumor Treating Fields, and may lead to the identification of new and exciting applications for this emerging technology.”\n\n\n2020 AACR-Novocure Career Development Awards for Tumor Treating Fields Research\n\n\n\nNarasimha Kumar Karanam, Ph.D., University of Texas Southwestern Medical Center\n“Harnessing E2F-Rb-CDK4/6 axis for novel combination therapy with TTFields”\n\n\nChirag B. Patel, M.D., Ph.D., Stanford University\n“Increasing glioblastoma cell membrane permeability with TTFields”\n\n\n\n2020 AACR-Novocure Tumor Treating Fields Research Grants\n\n\n\nCarsten Hagemann, Ph.D., Universitätsklinikum Würzburg, Germany\n“Overcoming the blood brain barrier drug ...